India’s medical device sector has experienced significant growth over the past decade, supported by healthcare expansion, technological innovation, and stronger regulatory oversight. A major milestone in this regulatory evolution was the introduction of the Medical Devices Rules, 2017, notified vide G.S.R. 78(E) dated 31 January 2017 by the Ministry of Health and Family Welfare under the Drugs and Cosmetics Act, 1940.

The Medical Devices Rules, 2017 established a dedicated regulatory framework for medical devices in India and introduced a risk-based licensing system governed jointly by the Central Drugs Standard Control Organization (CDSCO) and State Licensing Authorities (SLAs).

Among the most important regulatory bodies under this framework is the State Licensing Authority (SLA), which plays a central role in licensing, inspection, compliance monitoring, and enforcement for specified categories of medical devices.

This article explains the role, powers, responsibilities, and regulatory importance of the State Licensing Authority under G.S.R. 78(E).

What is the State Licensing Authority?

The State Licensing Authority (SLA) is the authority designated by the respective State Government under the Medical Devices Rules, 2017 for regulating specified categories of medical devices within the jurisdiction of that state.

In most states, this responsibility is carried out by the State Drug Controller or another designated regulatory officer.

The SLA functions as the primary state-level regulatory authority responsible for:

• Grant of manufacturing licences
• Inspection and verification
• Compliance monitoring
• Enforcement activities
• Oversight of sale and distribution activities

For medical device manufacturers and distributors, the SLA is often the first point of regulatory interaction at the state level.

Why the State Licensing Authority Was Introduced

India’s medical device industry is geographically widespread and includes manufacturers ranging from small enterprises to multinational companies. Regulating all approvals centrally would create administrative burden and approval delays.

To improve efficiency and strengthen regulatory oversight, the Medical Devices Rules, 2017 introduced a decentralized and risk-based regulatory structure:

• State Licensing Authorities regulate lower-risk device manufacturing
• Central Licensing Authority regulates higher-risk devices and imports
• Both authorities operate under a harmonized national framework

This approach allows:

• Faster licensing processes
• Better local oversight
• Improved inspection coverage
• Efficient compliance monitoring
• Stronger coordination between state and central regulators

The SLA therefore acts as an important bridge between local enforcement and national regulatory governance.

Risk-Based Classification under MDR 2017

Under the Medical Devices Rules, 2017, medical devices are classified according to risk as specified in the First Schedule:

• Class A – Low Risk
• Class B – Low-Moderate Risk
• Class C – Moderate-High Risk
• Class D – High Risk

The State Licensing Authority is primarily responsible for granting manufacturing licences for:

• Class A medical devices
• Class B medical devices

Manufacturing licences for Class C and Class D devices are regulated by the Central Licensing Authority (CLA) under CDSCO.

Responsibilities of the State Licensing Authority

1. Grant of Manufacturing Licences for Class A and Class B Devices

One of the primary functions of the SLA is the issuance of manufacturing licences for Class A and Class B medical devices under the Medical Devices Rules, 2017.

These categories may include:

• Surgical dressings
• Nebulizers
• Thermometers
• Blood pressure monitors
• Hospital consumables
• Certain diagnostic devices
• Certain in vitro diagnostic medical devices

Applications are submitted through the CDSCO Online System for Medical Devices along with required documentation such as:

• Device Master File
• Plant Master File
• ISO 13485 Quality Management System certification
• Technical specifications
• Labeling details
• Undertakings and declarations
• Applicable government fees

The SLA reviews the submitted documents and assesses regulatory compliance before granting approval through applicable forms under MDR 2017 such as Form MD-5 and related licensing forms.

2. Inspection and Verification of Manufacturing Sites

The SLA has authority to inspect manufacturing facilities both before and after licence issuance to ensure compliance with the Medical Devices Rules, 2017.

Pre-Licensing Inspection May Include:

• Verification of premises
• Equipment assessment
• Technical staff qualification review
• Documentation verification
• Quality Management System assessment
• Compliance with applicable standards

Post-Licensing Inspection May Include:

• Routine inspections
• Surprise audits
• Complaint investigations
• Corrective and preventive action verification
• Review of manufacturing records

These inspections help ensure continued compliance with:

• ISO 13485 requirements
• Good Manufacturing Practices (GMP)
• Applicable CDSCO standards
• Medical Devices Rules, 2017

For certain Class A devices, conformity assessment bodies may also be involved under applicable provisions of MDR 2017.

3. Oversight of Sale, Distribution, and Market Activities

The SLA also oversees the sale, stocking, exhibition, distribution, and retail activities of medical devices within the state through designated enforcement officers and drug inspectors.

This includes monitoring:

• Storage conditions
• Wholesale activities
• Retail supply
• Distribution chains
• Marketed products
• Exhibition activities

The objective is to ensure that only compliant and approved medical devices are available in the market.

This role is critical because medical devices directly impact patient safety and healthcare outcomes.

4. Enforcement and Regulatory Action

The State Licensing Authority has legal authority to take enforcement action under:

• The Drugs and Cosmetics Act, 1940
• Medical Devices Rules, 2017

Regulatory actions may include:

• Warning notices
• Show-cause notices
• Suspension of licence
• Cancellation of licence
• Product seizure
• Prosecution proceedings

Grounds for enforcement action may include:

• Manufacturing without licence
• Submission of false documentation
• Non-compliance with quality systems
• Unauthorized product changes
• Misbranding
• Failure to report adverse events
• Violation of MDR 2017 provisions

Where necessary, the SLA may coordinate with CDSCO and the Central Licensing Authority for regulatory action.

Application Process with the State Licensing Authority

Manufacturers applying for Class A or Class B manufacturing licences generally follow these steps:

Step 1: Device Classification

Determine the device classification according to the First Schedule of MDR 2017.

Step 2: Online Registration

Register on the CDSCO Online System for Medical Devices.

Step 3: Submission of Documentation

Submit:

• Device Master File
• Plant Master File
• ISO 13485 certificate
• Technical documentation
• Labeling information
• Application forms
• Undertakings and declarations
• Applicable fees

Step 4: Application Review

The SLA reviews the application and supporting documents.

Step 5: Inspection

Inspection may be conducted depending on device classification and regulatory requirements.

Step 6: Grant of Licence

If the application satisfies regulatory requirements, the manufacturing licence is granted.

Importance of the SLA for Medical Device Manufacturers

The State Licensing Authority plays an important operational and strategic role for manufacturers.

Faster Communication

Local regulatory interaction often enables quicker communication and procedural coordination.

Better Procedural Guidance

Manufacturers may receive guidance related to:

• Documentation requirements
• Licensing procedures
• Compliance obligations
• Amendments
• Renewals

Improved Regulatory Clarity

The SLA provides clarity regarding state-level compliance responsibilities and enforcement expectations.

Future Role of State Licensing Authorities in India

India’s medical device industry is expected to continue expanding due to:

• Domestic manufacturing initiatives
• Healthcare infrastructure growth
• Export opportunities
• Technological advancement
• Increased regulatory oversight

Accordingly, the role of State Licensing Authorities is expected to expand alongside:

• Digital regulatory systems
• Enhanced post-market surveillance
• Improved inspection mechanisms
• Harmonization with international regulatory practices
• Strengthened compliance monitoring

The SLA will continue to remain a key pillar of India’s medical device regulatory framework.

Conclusion

The State Licensing Authority under G.S.R. 78(E) is a vital component of India’s medical device regulatory ecosystem.

By regulating lower-risk medical devices at the state level, the SLA improves licensing efficiency while ensuring compliance with the Medical Devices Rules, 2017 and the Drugs and Cosmetics Act, 1940.

Its responsibilities in licensing, inspections, market surveillance, and enforcement contribute significantly to public health protection and regulatory accountability.

For manufacturers, importers, distributors, and regulatory professionals, understanding the role of the SLA is essential for successful medical device compliance and market access in India.

As India continues to strengthen its medical device sector, the State Licensing Authority will remain central to ensuring device safety, quality, and regulatory governance.